These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16640503)

  • 1. ICS-283: a system for targeted intravenous delivery of siRNA.
    Schiffelers RM; Storm G
    Expert Opin Drug Deliv; 2006 May; 3(3):445-54. PubMed ID: 16640503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
    Schiffelers RM; Ansari A; Xu J; Zhou Q; Tang Q; Storm G; Molema G; Lu PY; Scaria PV; Woodle MC
    Nucleic Acids Res; 2004 Nov; 32(19):e149. PubMed ID: 15520458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporting silence: design of carriers for siRNA to angiogenic endothelium.
    Schiffelers RM; Mixson AJ; Ansari AM; Fens MH; Tang Q; Zhou Q; Xu J; Molema G; Lu PY; Scaria PV; Storm G; Woodle MC
    J Control Release; 2005 Dec; 109(1-3):5-14. PubMed ID: 15979191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix systems for siRNA delivery.
    Naeye B; Raemdonck K; Remaut K; Demeester J; De Smedt SC
    Curr Top Med Chem; 2012; 12(2):89-96. PubMed ID: 22196275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment.
    Fujii H; Shin-Ya M; Takeda S; Hashimoto Y; Mukai SA; Sawada S; Adachi T; Akiyoshi K; Miki T; Mazda O
    Cancer Sci; 2014 Dec; 105(12):1616-25. PubMed ID: 25283373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy.
    Ding F; Mou Q; Ma Y; Pan G; Guo Y; Tong G; Choi CHJ; Zhu X; Zhang C
    Angew Chem Int Ed Engl; 2018 Mar; 57(12):3064-3068. PubMed ID: 29364558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold-installed biostable nanocomplexes for tumor-targeted siRNA delivery in vivo.
    Heo R; Yoon HY; Ko H; Shin JM; Jeon J; Chae YS; Kang YM; Kim D; Lee DS; Park JH
    Chem Commun (Camb); 2015 Dec; 51(93):16656-9. PubMed ID: 26426483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle.
    Yang Y; Meng Y; Ye J; Xia X; Wang H; Li L; Dong W; Jin D; Liu Y
    J Control Release; 2018 Oct; 287():103-120. PubMed ID: 30144476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
    Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
    Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of siRNA loaded dextran nanogel with blood cells.
    Naeye B; Raemdonck K; Demeester J; De Smedt SC
    J Control Release; 2010 Nov; 148(1):e90-1. PubMed ID: 21529653
    [No Abstract]   [Full Text] [Related]  

  • 14. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
    Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
    Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
    Wang B; Ding Y; Zhao X; Han X; Yang N; Zhang Y; Zhao Y; Zhao X; Taleb M; Miao QR; Nie G
    Biomaterials; 2018 Aug; 175():110-122. PubMed ID: 29803999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.